American Portfolios Advisors’s Bristol-Myers Squibb BMY Stock Holding History

American Portfolios Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.1M	Sell	43,553 -10,045	-19%	-$729K	0.13%	167
2022 Q2	$4.13M	Buy	53,598 +7,755	+17%	+$591K	0.17%	121
2022 Q1	$3.35M	Buy	45,843 +4,273	+10%	+$287K	0.11%	185
2021 Q4	$2.59M	Buy	41,570 +5,243	+14%	+$308K	0.09%	235
2021 Q3	$2.15M	Buy	36,327 +1,693	+5%	+$111K	0.08%	258
2021 Q2	$2.31M	Buy	34,634 +582	+2%	+$38K	0.09%	230
2021 Q1	$2.15M	Sell	34,052 -1,399	-4%	-$87K	0.09%	209
2020 Q4	$2.2M	Sell	35,451 -793	-2%	-$48.8K	0.11%	180
2020 Q3	$2.19M	Buy	36,244 +9,979	+38%	+$601K	0.13%	158
2020 Q2	$1.54M	Sell	26,265 -1,847	-7%	-$110K	0.1%	194
2020 Q1	$1.57M	Sell	28,112 -14,054	-33%	-$859K	0.13%	155
2019 Q4	$2.71M	Buy	42,166 +12,497	+42%	+$716K	0.19%	121
2019 Q3	$1.5M	Buy	29,669 +3,099	+12%	+$146K	0.12%	168
2019 Q2	$1.2M	Buy	26,570 +4,398	+20%	+$205K	0.1%	203
2019 Q1	$1.06M	Buy	22,172 +2,597	+13%	+$129K	0.1%	208
2018 Q4	$1.02M	Sell	19,575 -1,839	-9%	-$98.8K	0.13%	166
2018 Q3	$1.33M	Buy	21,414 +254	+1%	+$15.1K	0.15%	133
2018 Q2	$1.17M	Buy	21,160 +128	+0.6%	+$6.91K	0.16%	128
2018 Q1	$1.33M	Buy	21,032 +2,457	+13%	+$158K	0.2%	110
2017 Q4	$1.14M	Buy	+18,575	New	+$1.16M	0.18%	126

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Portfolios Advisors's BMY Position: Q3 2022 in Review

American Portfolios Advisors reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q3 2022, selling an estimated $729K and leaving 43,553 shares worth $3.1M. The position accounts for 0.13% of the portfolio, ranked #167.

American Portfolios Advisors first reported a position in BMY in Q4 2017 and has held it in 20 quarters since. The position peaked at $4.13M in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

American Portfolios Advisors held 43,553 shares of Bristol-Myers Squibb worth $3.1M as of Q3 2022.
American Portfolios Advisors sold 10,045 Bristol-Myers Squibb shares in Q3 2022, an estimated $729K.
Bristol-Myers Squibb made up 0.13% of American Portfolios Advisors's portfolio in Q3 2022, its #167 holding.
American Portfolios Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Bristol-Myers Squibb position peaked at $4.13M in Q2 2022.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.